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Analysis of Subgroup Data of Clinical Trials
January 31, 2014
A collaborative study including Dr. Kao-Tai Tsai, adjunct professor of biostatistics, and Dr. Karl
E. Peace, professor of biostatistics, at the Jiann-Ping Hsu College of Public Health Georgia
Southern University propose an analysis strategy of subgroup data of clinical trials. Large
randomized controlled clinical trials are the gold standard to evaluate and compare the effects
of treatments. It is common practice for investigators to explore and even attempt to compare
treatments, beyond the first round of primary analyses, for various subsets of the study
populations based on scientific or clinical interests to take advantage of the potentially rich
information contained in the clinical database. Although subjects are randomized to treatment
groups in clinical trials, this does not imply the same degree of randomization among sub-
populations of the original trials. Therefore, comparisons of treatments in sub-populations may
not produce fair and unbiased results without properly addressing this issue. Covariate adjustments in regression
analysis and propensity score matching are commonly used to address the non-randomized nature of the sub-
populations issue with various degrees of success. However, further improvements to these methods are still
possible.
In this article, we propose an analysis strategy that shows improvement to conventional methods. Treatment
effects and their differences are estimated after adjustment for background imbalances. Treatment groups are
then compared using confidence intervals whose limits are determined using the Robbins–Monro stochastic
approximation. Data from a recent clinical trial are used to illustrate the methodology.
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